Abstract
The penetration of ciprofloxacin into bronchial secretions was evaluated in 21 patients after a single oral dose of 500 mg of ciprofloxacin. Ten successive serum samples were collected in the interval 0–12 h after administration, and bronchial samples were taken 2, 3, 4 and 6 h after administration. Concentrations were measured in all samples using a standard microbiological assay. The results showed that the kinetics in serum did not differ from those determined in previous studies, a peak level of 2.2±1.3 mg/l being achieved at 2 h followed by a slow decrease of the levels to 0.6±0.4 mg/l at 6 h. The bronchial concentrations reached about 0.5 mg/l at 2 h and remained stable until 6 h, ranging between 0.5 and 0.8 mg/l. The ratio between simultaneous bronchial and serum levels ranged from 0.19 at 2 h to 0.95 at 6 h. These data indicate that ciprofloxacin might be suitable for treatment of severe respiratory infections, especially pneumonia caused byPseudomonas aeruginosa, since the MICs of ciprofloxacin for most bacteria involved in bronchopulmonary infections are very low and tissue diffusion of the drug in the respiratory tract is good.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wise, R., Lockley, R. M., Webberly, M., Dent, J.: Pharmacokinetics of intravenously administered ciprofloxacin. Antimicrobial Agents and Chemotherapy 1984, 26: 208–210.
Crump, B., Wise, R., Dent, J.: Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1983, 24: 784–786.
Shah, P. M., Strehl, R., Posselt, H. G., Bender, S. W.: Ciprofloxacin bei Mukoviszidose zystiche Fibrose, eine pharmakokinetische Untersuchung. Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie 1984, 3: 685–690.
Davis, R. L., Koup, J. R., Williams-Warren, J., Weber, A., Smith, A. L.: Pharmacokinetics of three oral formulations of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1985, 28: 74–77.
Bergan, T.: Pharmacokinetics of tissue penetration of antibiotics. Reviews of Infectious Diseases 1981, 3: 45–65.
Bergogne-Bérézin, E.: Pharmacokinetics of antibiotics in respiratory secretions. In: T. Pennington, J. E. (ed.): Respiratory infections: diagnosis and management. Raven Press, New York, 1983, p. 461–479.
Morel, C., Vergnaud, M., Langeard, M. M., Monrocq, N.: Pefloxacin diffusion into the bronchial mucus. In: Spitzy, C. H., Karrer, C. (ed.): Proceedings of the 13th International Congress of Chemotherapy, Vienna, 1983, p. 110/32–38.
Davies, B. I., Maesen, F. P. V., Teengs, J. P.: Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study. Journal of Antimicrobial Chemotherapy 1984, 14, Supplement C: 83–89.
Yamaguchi, K., Nakazato, H., Koga, H., Watanabe, K., Tomita, H., Tanaka, H., Hohno, S., Ito, N., Fujita, K., Shigeno, Y., Suzuyama, Y., Saito, A., Hara, K.: Laboratory studies and clinical evaluation of DL-8280 to the patients with respiratory infections. Chemotherapy (Tokyo) 1984, 32, Supplement 1: 487–508.
Barry, A. L., Jones, R. N., Thornsberry, C., Ayers, L. W., Gerlach, E. H., Sommers, H. M.: Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin and nalidixic acid. Antimicrobial Agents and Chemotherapy 1984, 25: 633–637.
Ruckdeschel, G., Ehret, W., Ahl, A.: Susceptibility ofLegionella species to quinolone derivatives and related organic acid. European Journal of Clinical Microbiology 1984, 3: 373.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bergogne-Bérézin, E., Berthelot, G., Even, P. et al. Penetration of ciprofloxacin into bronchial secretions. Eur. J, Clin. Microbiol. 5, 197–200 (1986). https://doi.org/10.1007/BF02013986
Issue Date:
DOI: https://doi.org/10.1007/BF02013986